EBC - ON DEMAND
European Bifurcation Club 2015 – EBC 2015 – Athens, Greece
News (2)
Systemaic treatment of the side branch in a bifurcation lesion with a new drug eluting balloon: the DEBSIDE study. 12 months results
Author: Eduardo APTECAR, Clinique les Fontaines, MELUN, FRANCE
CONCLUSION
- Systematic final inflation of a drug-eluting balloon (DANUBIO) in the side branch after placement of a drug-eluting dedicated stent (Nile PAX) in the main vessel for the treatment of bifurcation lesions resulted in a very low late lumen loss (-0.04±0.34mm) and restenosis rate (2.0%) at the side branch ostium.
- Although suboptimal angiographic results obtained in the main branch were observed, they did not impact the good clinical (TLR in SB = 2.0%) and angiographic results in the side branch.
- Additional and complementary studies with larger populations, combining newer-generation limus-eluting stents, which could enable beper results on the main branch, along with the DANUBIO drug-eluting balloon would certainly be of especial interest.
- In this context, a sirolimus-eluting version of the Nile dedicated stent platform is currently being developed.